RIPK1 and colitis: One study has found that the levels of RIP1 and RIP3 are significantly increased in mice with dextran sulfate sodium- (DSS-) induced colitis and that the RIPK inhibitor necrostatin-1 can effectively inhibit the RIP1/RIP3 interaction, thereby inhibiting intestinal inflammation [12].